Literature DB >> 8260829

Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease.

H Wekerle1.   

Abstract

Experimental autoimmune encephalomyelitis models are used to analyze the generation and organization of the myelin-specific autoimmune repertoire, and potential immunoregulatory loops preventing spontaneous activation of encephalitogenic T cells. These lymphocytes are profoundly modulated by infectious agents, which may trigger, or more commonly, prevent experimental autoimmune encephalomyelitis. The development and resolution of the pathogenic central nervous system infiltrations is controlled by locally produced cytokines that cause recruitment of infiltrate cells, and their disappearance. Several of the new findings seem now to be applicable for therapeutic strategies, especially with the aim of interfering with immunospecific recognition steps involved in disease generation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260829     DOI: 10.1016/0959-4388(93)90153-p

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  19 in total

1.  The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Authors:  B Bourrié; E Bribes; M Esclangon; L Garcia; J Marchand; C Thomas; J P Maffrand; P Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.

Authors:  Joel N H Stern; Derin B Keskin; Zenichiro Kato; Hanspeter Waldner; Sonja Schallenberg; Ana Anderson; Harald von Boehmer; Karsten Kretschmer; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

Review 3.  Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.

Authors:  Cathleen Petzold; Sonja Schallenberg; Joel N H Stern; Karsten Kretschmer
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques.

Authors:  E MeinL; R M Hoch; K Dornmair; R de Waal Malefyt; R E Bontrop; M Jonker; H Lassmann; R Hohlfeld; H Wekerle; B A 't Hart
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 5.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

Review 6.  Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis.

Authors:  Hans-Peter Hartung; Bernd C Kieseier; Bernhard Hemmer
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

7.  Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop.

Authors:  J Bergquist; A Tarkowski; R Ekman; A Ewing
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading.

Authors:  Gizi Wildbaum; Nir Netzer; Nathan Karin
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 9.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.

Authors:  Mayumi Fujita; Takao Otsuka; Miho Mizuno; Chiharu Tomi; Takashi Yamamura; Sachiko Miyake
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.